- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2195-9595
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Natural History of NAFLD/NASH ; volume:16 ; number:4 ; day:13 ; month:11 ; year:2017 ; pages:391-397 ; date:12.2017
Current hepatology reports ; 16, Heft 4 (13.11.2017), 391-397, 12.2017
- Urheber
-
Ekstedt, Mattias
- Beteiligte Personen und Organisationen
-
Nasr, Patrik
Kechagias, Stergios
SpringerLink (Online service)
- DOI
-
10.1007/s11901-017-0378-2
- URN
-
urn:nbn:de:1111-201802241497
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ekstedt, Mattias
- Nasr, Patrik
- Kechagias, Stergios
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4
The role of the microbiome in NAFLD and NASH
Current and future pharmacological therapies for NAFLD/NASH
Pharmacological inhibition of mINDY for the treatment of NAFLD/NASH
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Deep learning-based quantification of NAFLD/NASH progression in human liver biopsies
Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation
BMP4 and Gremlin 1 regulate hepatic cell senescence during clinical progression of NAFLD/NASH
Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
Lebens- und Schlafqualität bei Patienten mit einer Nicht-Alkoholischen-Fettleber (NAFLD) in Abhängigkeit der Leberfunktion – eine LiMax-NAFLD/NASH-Studie
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future